Diseases once thought confined to history are making a comeback in Australia. And vaccination is only part of the story.
Articles on Disease control
Displaying 1 - 20 of 51 articles
Six passengers from the hantavirus-struck cruise ship are in quarantine in Australia. So how do we actually design buildings to keep a virus from spreading?
Antibiotic prescribing around the time of surgery and in aged care isn’t always appropriate, a new report shows. Here’s what else we learned.
Mosquitoes cause around a million deaths per year. So, scientists are coming up with genetic engineering techniques that could lower their numbers.
Climate change is causing this disease to spread in Southern Europe, but governments are doing little to prevent it.
With a new 5-in-1 vaccine, Nigeria hopes to contain the five most important serotypes causing meningitis in the country.
Beyond the tombs and riches, life in ancient Egypt wasn’t so luxurious, after all.
The response to the crisis in India speaks to the complexity of public health decision-making.
Why the virus just keeps spreading – and what to do about it.
With a vaccine, yes, elimination is possible. But we need to be realistic about how long this might take.
Opposition leader Anthony Albanese has announced an initiative that would see a Labor government implement an Australian Centre for Disease Control.
Will the COVID-19 pandemic change the global balance of power? It wouldn’t be the first time.
The US response to the coronavirus was slow and problematic, but it also was rooted in a 19th-century way of viewing public health.
Social distancing and physical changes to the environment pose significant challenges to people with visual impairments.
Suppression tactics aren’t appropriate for dangerous diseases – and in the long term prove just as expensive.
Lowering urban density to protect against the coronavirus would be a misguided response. Density is not a key driver of infection, and keeps people active and healthy.
Currently, there is no evidence that this highly effective antimalarial can treat COVID-19 – and the threat of drug resistance should deter us from using it indiscriminately.
New Zealand has managed it, but densely populated, highly infected countries face a bigger challenge.
While the delay to releasing the app is disappointing, it’s a chance to use behavioural science to optimise its design.
A rapid launch of tracing and testing combined with localised lockdowns aims to keep the virus under control until a vaccine is found.
Top contributors
-
Professor of Public Health, University of Sheffield
-
Professor, Swansea University
-
Fellow, Nigerian Academy of Science
-
Professor of Biostatistics and Epidemiology, Adelaide University
-
Distinguished Research Professor, Emerita, Dalhousie University
-
Visiting Lecturer of History, Georgia State University
-
Senior Lecturer, UNSW
-
Professor, School of Population Health, UNSW
-
Senior Principal Research Scientist, Ecosystem Sciences, CSIRO
-
Professor of Entomology and Disease Epidemiology, Penn State
-
Program Leader Effective Detection and Response, Plant Biosecurity Cooperative Research Centre
-
Senior Lecturer in Communicable Disease Epidemiology, University of Sydney
-
Infectious Diseases Lead, King's Sierra Leone Partnership, King's College London
-
Associate Professor, School of Mathematical Sciences, Monash University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW